Fibrinogen alpha chain, encoded by the FGA gene in humans, is one of the three polypeptide chains that make up the protein fibrinogen, the others being the beta and gamma chains. Fibrinogen is a blood-borne glycoprotein and plays a critical role in the clotting of blood, making it essential for wound healing and preventing excessive bleeding.The fibrinogen alpha chain, together with the beta and gamma chains, forms a hexameric structure composed of two sets of these three chains. The alpha chains contribute to the formation of fibrin, the main protein involved in blood clotting.Upon tissue injury and the initiation of the clotting cascade, the enzyme thrombin cleaves fibrinogen, releasing fibrinopeptide A from the alpha chain. This action converts fibrinogen into fibrin, which then polymerizes to form a fibrin clot. The clot acts as a scaffold for platelet aggregation, stabilizes the wound site, and aids in preventing blood loss.
The fibrinogen alpha chain also interacts with various other proteins such as fibronectin, factor XIII, and integrin, which enhance clot structure and stability.Mutations in the FGA gene can lead to several disorders. These include afibrinogenemia, characterized by the absence of fibrinogen, and dysfibrinogenemia, characterized by dysfunctional fibrinogen. Both conditions can lead to bleeding disorders or thrombosis.In summary, the fibrinogen alpha chain is a vital component of the blood clotting process, contributing to the formation of fibrin clots that help prevent excessive bleeding. Mutations in the FGA gene can disrupt this process, leading to a range of blood clotting disorders. Understanding this protein is therefore crucial in the field of hematology and coagulation studies.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vitamin K1 | 84-80-0 | sc-280189 sc-280189A | 1 g 5 g | $81.00 $166.00 | ||
Essential for the synthesis of clotting factors, potentially influencing the function of fibrinogen in the clotting process. | ||||||
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
Vital for blood coagulation cascade, potentially affecting the conversion of fibrinogen to fibrin. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Directly converts fibrinogen to fibrin; its presence is crucial for fibrinogen activation in clot formation. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
Involved in enhancing the strength of clot formation, could indirectly influence fibrinogen's role in clotting. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Can promote coagulation and enhance the clotting process, potentially affecting fibrinogen's activity. | ||||||
Oxytocin acetate salt | 50-56-6 | sc-279938 sc-279938A sc-279938B sc-279938C sc-279938D sc-279938E | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $60.00 $180.00 $337.00 $663.00 $969.00 $1836.00 | 4 | |
Known to have a role in promoting coagulation, potentially affecting fibrinogen function. | ||||||
Argatroban | 74863-84-6 | sc-201310 sc-201310A | 10 mg 50 mg | $117.00 $469.00 | 13 | |
A thrombin inhibitor that, through its regulatory effects on thrombin, could indirectly influence fibrinogen's role in clot formation. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
An anticoagulant that indirectly affects the clotting cascade and fibrinogen's role in it. | ||||||
Warfarin | 81-81-2 | sc-205888 sc-205888A | 1 g 10 g | $73.00 $246.00 | 7 | |
Anticoagulant that affects clotting factor synthesis; its effects can indirectly influence fibrinogen's function in clot formation. | ||||||